DIVIDEND ANNOUNCEMENT: Catalyst Biosciences Inc (NASDAQ:CBIO) on 08/25/2022 declared a dividend of $1.4300 per share

Catalyst Biosciences Inc (NASDAQ:CBIO) on 08/25/2022 declared a dividend of $ 1.4300 per share payable on September 20, 2022 to shareholders of record as of September 06, 2022. Dividend amount recorded is an increase of $ 1.43 from last dividend Paid.

Catalyst Biosciences Inc (NASDAQ:CBIO) has paid dividends since 1970, has a current dividend yield of 0.0000000000% and has increased its dividends for 0 successive years.

Catalyst Biosciences Inc's market cap is $ 62,639,230 and has a PE ratio of 0.00. The stock price closed yesterday at $ 1.99 and has a 52 week low/high of $ 0.35 and $ 5.20.

Catalyst Biosciences is a research and clinical development biopharmaceutical company. Co.'s complement portfolio consists of the development candidates CB 4332 and CB 2782-PEG. CB 4332 is a wholly owned, improved albumin-fused Complement Factor I (CFI) molecule intended for prophylactic subcutaneous or intravitreal administration in individuals with an imbalance in complement homeostasis or a CFI deficiency. CB 2782-PEG is a potential component 3 degrader product candidate in preclinical development for the treatment of dry age-related macular degeneration. Co. has several engineered protease programs in discovery or early non-clinical development.

For more information on Catalyst Biosciences Inc click here.